Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
Article in The Lancet (February 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in The Lancet (February 2024)
Article in The Lancet Rheumatology (February 2024)
Article in Rheumatology (November 2023)